Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias
Objective. To improve the reproductive health of women with benign breast dysplasia (BBD) and uterine myoma, by elaborating a differentiated approach to preventing and treating comorbid diseases. Subject and methods. The investigation included 175 women with concomitant genital diseases and BBD who...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House TRILIST
2017-09-01
|
| Series: | Репродуктивная эндокринология |
| Subjects: | |
| Online Access: | http://reproduct-endo.com/article/view/110062 |
| _version_ | 1811334512261464064 |
|---|---|
| author | В. Е. Радзинский И. М. Ордиянц М. Н. Масленникова Е. А. Павлова В. В. Карданова |
| author_facet | В. Е. Радзинский И. М. Ордиянц М. Н. Масленникова Е. А. Павлова В. В. Карданова |
| author_sort | В. Е. Радзинский |
| collection | DOAJ |
| description | Objective. To improve the reproductive health of women with benign breast dysplasia (BBD) and uterine myoma, by elaborating a differentiated approach to preventing and treating comorbid diseases.
Subject and methods. The investigation included 175 women with concomitant genital diseases and BBD who were treated at the Gynecology Unit of the City Clinical Hospital No. 12, Moscow. The results of their examination and differentiated treatment for comorbid diseases of the uterus and breast were analyzed.
Results. The altered ratio of steroid hormone levels as absolute or relative hyperestrogenemia underlies the pathogenesis of BBD in women with uterine myoma. The elaborated differentiated approach allows quality of life to be improved of 43.4% of patients with combined diseases of the mammary glands and genitals, to reduce the progression and recurrence of BBD in patients with uterine myoma from 36.7 to 15.9%.
Conclusion. The findings strongly suggest that the women of this category must form a special follow-up gynecological group and their treatment must be a preventive measure against the progression and recurrence of BBD. |
| first_indexed | 2024-04-13T17:09:07Z |
| format | Article |
| id | doaj.art-906a2faa5e364605b09121a7ed190832 |
| institution | Directory Open Access Journal |
| issn | 2309-4117 2411-1295 |
| language | English |
| last_indexed | 2024-04-13T17:09:07Z |
| publishDate | 2017-09-01 |
| publisher | Publishing House TRILIST |
| record_format | Article |
| series | Репродуктивная эндокринология |
| spelling | doaj.art-906a2faa5e364605b09121a7ed1908322022-12-22T02:38:20ZengPublishing House TRILISTРепродуктивная эндокринология2309-41172411-12952017-09-0136868910.18370/2309-4117.2017.36.86-89101832Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasiasВ. Е. Радзинский0И. М. Ордиянц1М. Н. Масленникова2Е. А. Павлова3В. В. Карданова4Peoples’ Friendship University of Russia, Moscow, Russian FederationPeoples’ Friendship University of Russia, Moscow, Russian FederationCity Clinical Hospital No. 12, Moscow, Russian FederationPeoples’ Friendship University of Russia, Moscow, Russian FederationPeoples’ Friendship University of Russia, Moscow, Russian FederationObjective. To improve the reproductive health of women with benign breast dysplasia (BBD) and uterine myoma, by elaborating a differentiated approach to preventing and treating comorbid diseases. Subject and methods. The investigation included 175 women with concomitant genital diseases and BBD who were treated at the Gynecology Unit of the City Clinical Hospital No. 12, Moscow. The results of their examination and differentiated treatment for comorbid diseases of the uterus and breast were analyzed. Results. The altered ratio of steroid hormone levels as absolute or relative hyperestrogenemia underlies the pathogenesis of BBD in women with uterine myoma. The elaborated differentiated approach allows quality of life to be improved of 43.4% of patients with combined diseases of the mammary glands and genitals, to reduce the progression and recurrence of BBD in patients with uterine myoma from 36.7 to 15.9%. Conclusion. The findings strongly suggest that the women of this category must form a special follow-up gynecological group and their treatment must be a preventive measure against the progression and recurrence of BBD.http://reproduct-endo.com/article/view/110062benign breast dysplasiauterine myoma |
| spellingShingle | В. Е. Радзинский И. М. Ордиянц М. Н. Масленникова Е. А. Павлова В. В. Карданова Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias Репродуктивная эндокринология benign breast dysplasia uterine myoma |
| title | Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias |
| title_full | Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias |
| title_fullStr | Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias |
| title_full_unstemmed | Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias |
| title_short | Possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias |
| title_sort | possibilities for therapy of a comorbidity of uterine myoma and benign breast dysplasias |
| topic | benign breast dysplasia uterine myoma |
| url | http://reproduct-endo.com/article/view/110062 |
| work_keys_str_mv | AT veradzinskij possibilitiesfortherapyofacomorbidityofuterinemyomaandbenignbreastdysplasias AT imordiânc possibilitiesfortherapyofacomorbidityofuterinemyomaandbenignbreastdysplasias AT mnmaslennikova possibilitiesfortherapyofacomorbidityofuterinemyomaandbenignbreastdysplasias AT eapavlova possibilitiesfortherapyofacomorbidityofuterinemyomaandbenignbreastdysplasias AT vvkardanova possibilitiesfortherapyofacomorbidityofuterinemyomaandbenignbreastdysplasias |